British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic

Abstract

During the COVID-19 pandemic, pressures on clinical services required adaptation to how care was prioritised and delivered for women with gynaecological cancer. This document discusses potential 'salvage' measures when treatment has deviated from the usual standard of care. The British Gynaecological Cancer Society convened a multi-disciplinary working group to develop recommendations for the onward management and follow-up of women with gynaecological cancer who have been impacted by a change in treatment during the pandemic. These recommendations are presented for each tumour type and for healthcare systems, and the impact on gynaecological services are discussed. It will be important that patient concerns about the impact of COVID-19 on their cancer pathway are acknowledged and addressed for their ongoing care.

Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

“…Yet, few health systems have established consensus agreements to date. 1,8 These results will also add to the evidence for future pandemics and the planning of relevant studies during a worldwide crisis in the future.…”

Spotlight on … gynaecological cancer

“…Looking back, it has been an eventful 5 years! While the British Gynaecological Cancer Society (BGCS) has been busy drafting guidelines for management of patients affected by the COVID‐19 pandemic, 1 our community has also been busy updating TOG on significant advances in the understanding and treatment of gynaecological cancers. Thank you to the excellent author teams for sharing their knowledge and insights, exploring topics I hope will be relevant to both gynaecological oncologists and those with other specialist interests.…”